ALDH1A1 and triple-negative breast carcinoma: In this study, we can conclude that the one-year survival rate for triple-negative breast cancer patients with positive ALDH1 expression was 42.9% and the one-year survival rate for triple-negative breast cancer patients with negative ALDH1 expression was 78.8%, also the three-year survival rate for triple-negative breast cancer patients with positive ALDH1 expression was 33.3%, and the three-year survival rate for triple-negative breast cancer patients with negative ALDH1 expression was 72.7%.